Lawrence L. Rudel
Affiliations: | Wake Forest University School of Medicine, Winston-Salem, NC, United States |
Area:
Pathology, BiochemistryWebsite:
https://www.wakehealth.edu/Research/Lipid-Science/Lawrence-L--Rudel,-PhD.htmGoogle:
"Lawrence L. Rudel"Bio:
https://www.bloomberg.com/research/stocks/private/person.asp?personId=321399206&privcapId=204765597&previousCapId=141530835&previousTitle=Cleave%20Biosciences,%20Inc.
https://books.google.com/books?id=RvocAAAAMAAJ
Mean distance: (not calculated yet)
Parents
Sign in to add mentorManford Donald Morris | grad student | 1970 | University of Arkansas, Fayetteville | |
(Studies on exogenous cholesterol metabolism in the normal rabbit, time course of 7α-3H-cholesterol appearance in plasma lipoproteins, liver and intestinal mucosal cells.) |
Children
Sign in to add traineeCharles W. Joyce | grad student | 2000 | Wake Forest School of Medicine |
Kirsten J. Williford | grad student | 2000 | Wake Forest School of Medicine |
Heather M. Alger | grad student | 2009 | Wake Forest School of Medicine |
Akash Das | grad student | 2009 | Wake Forest School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Helsley RN, Venkateshwari V, Brown AL, et al. (2019) Obesity-linked suppression of membrane-bound -Acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. Elife. 8 |
Ruuth M, Nguyen SD, Vihervaara T, et al. (2018) Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths. European Heart Journal |
Ohshiro T, Kobayashi K, Ohba M, et al. (2017) Selective inhibition of sterolO-acyltransferase 1 isozyme by beauveriolide III in intact cells. Scientific Reports. 7: 4163 |
Sacks FM, Lichtenstein AH, Wu JHY, et al. (2017) Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation |
Warrier M, Zhang J, Bura K, et al. (2016) Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss. Lipids |
Ohshiro T, Ohtawa M, Nagamitsu T, et al. (2015) New Pyripyropene A Derivatives, Highly SOAT2-Selective Inhibitors, Improve Hypercholesterolemia and Atherosclerosis in Atherogenic Mouse Models. The Journal of Pharmacology and Experimental Therapeutics |
Lopez AM, Chuang JC, Posey KS, et al. (2015) PRD125, a Potent and Selective Inhibitor of Sterol O-acyltransferase 2 (SOAT2) Markedly Reduces Hepatic Cholesteryl Ester Accumulation and Improves Liver Function in Lysosomal Acid Lipase-deficient Mice. The Journal of Pharmacology and Experimental Therapeutics |
Melchior JT, Olson JD, Kelley KL, et al. (2015) Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 1920-7 |
Jones PJ, MacKay DS, Senanayake VK, et al. (2015) High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans. Atherosclerosis. 238: 231-8 |
Shores NJ, Verhague MA, Sawyer JK, et al. (2015) Su1036 Hepatic Apolipoprotein A-IV Gene Expression Is Increased in Non-Alcoholic Fatty Liver Disease and Is Modulated by Gender and Inflammation Gastroenterology. 148: S-1045 |